BioReperia

Private

LinköpingHealthcare & Life Scienceshttps://bioreperia.com/

Last Round

Grant

Apr 13, 2021

Total Funding Raised

$1.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

BioReperia is a biotechnology company that provides a zebrafish tumor xenograft (ZTX®) platform used to accelerate drug discovery and predict the efficacy of cancer treatments for personalized medicine.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

contract research organizationCROzebrafish tumor xenograftcancer drug discoverypersonalized medicineprecision oncologyzebrafish modelpatient avatarZTX platformin-vivo testingtumor efficacy testingpreclinical drug discoveryclinical decision supportmetastasis analysispatient-derived xenograftPDX modelsimmune oncology modelingtoxicology services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioReperia Comps

Public and private peers based on sector, stage, and business model.

BioReperia comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BioReperia Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Apr 13, 2021
Series A	Jul 1, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Anna Erkstam

Chief Executive Officer

Executive Team

Lasse Jensen

Chief Technology Officer

Executive Team

BioReperia Investors

Notable investors and investment history

BioReperia investors
Investor	Rounds
LiU Invest	Seed
Almi Invest AB	Series A
Swelife	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 22, 2026
Monthly visitors increased 49% MoM.
Jan 1, 2026
Monthly visitors increased 37% MoM.

View all signals

BioReperia Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

BioReperia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioReperia's valuation, stock price, and market status.

Firmographic Details

HeadquartersLinköping

Employee Range20

Year Founded2015

Last FundingApr 13, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.